HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by Toronto Dominion Bank

Toronto Dominion Bank grew its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 134.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 226,811 shares of the company's stock after acquiring an additional 130,076 shares during the period. Toronto Dominion Bank owned about 0.09% of HCA Healthcare worth $68,076,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Sanders Capital LLC raised its position in shares of HCA Healthcare by 1.0% during the fourth quarter. Sanders Capital LLC now owns 11,655,563 shares of the company's stock valued at $3,498,417,000 after buying an additional 116,826 shares during the last quarter. First Eagle Investment Management LLC lifted its stake in HCA Healthcare by 0.5% in the 4th quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company's stock worth $1,351,830,000 after purchasing an additional 23,177 shares in the last quarter. Geode Capital Management LLC grew its position in shares of HCA Healthcare by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company's stock valued at $1,159,882,000 after purchasing an additional 50,321 shares in the last quarter. Capital World Investors lifted its position in shares of HCA Healthcare by 0.7% in the fourth quarter. Capital World Investors now owns 2,928,452 shares of the company's stock worth $878,975,000 after buying an additional 19,121 shares in the last quarter. Finally, Norges Bank purchased a new position in HCA Healthcare during the 4th quarter valued at approximately $840,286,000. Institutional investors own 62.73% of the company's stock.

Insider Activity at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer now owns 12,646 shares of the company's stock, valued at $4,670,420.72. This trade represents a 55.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.30% of the stock is owned by company insiders.

HCA Healthcare Stock Down 1.4%

Shares of HCA stock traded down $5.28 during trading hours on Thursday, reaching $376.53. 1,250,400 shares of the company's stock were exchanged, compared to its average volume of 1,435,385. The stock has a market cap of $90.58 billion, a PE ratio of 17.14, a PEG ratio of 1.10 and a beta of 1.46. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The stock's fifty day moving average price is $344.86 and its two-hundred day moving average price is $329.27.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The business had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The company's revenue was up 5.7% on a year-over-year basis. During the same period in the prior year, the company earned $5.36 earnings per share. Research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.76%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on HCA shares. Barclays lowered their price objective on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a research note on Monday, January 27th. Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Guggenheim began coverage on HCA Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating for the company. Bank of America decreased their price target on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research note on Monday, January 27th. Finally, Cantor Fitzgerald reiterated an "overweight" rating and issued a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, six have given a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare has an average rating of "Moderate Buy" and an average price target of $381.13.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.